← All comparisons
FP Markets
VS
FXCM

FP Markets vs FXCM: which broker is better in 2026?

We compare FP Markets and FXCM — two forex & CFD brokers — side by side across regulation, fees, platforms, minimum deposit, and our editorial scores. Based on our overall editorial score, FP Markets edges ahead (3.8/5), but the right choice depends on what matters most to you — check the breakdown below.

Side-by-side comparison

CriteriaFP MarketsFXCM
Overall score 3.8 3.5
Regulation & safety 3.5 3.0
Fees & deposit 4.0 3.5
Platform & assets 4.0 4.0
User support 3.5 3.5
Trust score74/10068/100
Minimum depositVaries by account type — check the official siteVaries by account type — check the official site
Demo accountAvailableAvailable
PlatformsMetaTrader 4, MetaTrader 5, cTrader, IRESSTrading Station (web/desktop/mobile), MetaTrader 4, TradingView (integrated), API
Fee modelRaw spread + commission (Raw) or Standard; competitiveSpread model or spread + commission (Active Trader) — varies; exact figures not yet verified

Pros & cons

FP Markets
  • ASIC/CySEC regulation + full platform selection (including IRESS for stocks)
  • Competitive raw spreads
  • Operating since 2005
  • The global entity (St. Vincent) is less strict than ASIC/CySEC
  • Mid-size brand, not a tier-1 giant
  • Leverage is high-risk
FXCM
  • An established broker since 1999 with the mature Trading Station & MT4 platforms
  • Now backed by a large financial group (Jefferies/StoneX)
  • International entities regulated by FCA/ASIC/FSCA
  • Permanently banned from the US market (2017) + a US$7 million fine for hiding a conflict of interest — a serious regulatory record
  • Trust was dented by that case; verify the entity serving your region
  • Leveraged products are high-risk

Regulation at a glance

FP Markets

Australian (2005) — regulated by ASIC (Australia), CySEC (Cyprus), FSA (St. Vincent for the global entity).

FXCM

International entities regulated by the FCA (UK), ASIC (Australia), FSCA (South Africa), and others. IMPORTANT: FXCM has been permanently banned from the US market since 2017 (see the risk note).